Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods.

English, Emma; Cook, Laura E; Piec, Isabelle; Dervisevic, Samir; Fraser, William D; John, W Garry

English, Emma; Cook, Laura E; Piec, Isabelle; Dervisevic, Samir; Fraser, William D; John, W Garry.

Afiliação

English E; Faculty of Medicine and Health, University of East Anglia, Norfolk, United Kingdom.
Cook LE; Department of Clinical Biochemistry and Immunology, Norfolk and Norwich University Hospital, Norfolk, United Kingdom.
Piec I; Department of Clinical Biochemistry and Immunology, Norfolk and Norwich University Hospital, Norfolk, United Kingdom.
Dervisevic S; Faculty of Medicine and Health, University of East Anglia, Norfolk, United Kingdom.
Fraser WD; Faculty of Medicine and Health, University of East Anglia, Norfolk, United Kingdom.
John WG; Department of Virology, Norfolk and Norwich University Hospital, Norfolk, United Kingdom.

J Clin Microbiol ; 59(9): e0028821, 2021 08 18.

Article em En | MEDLINE | ID: mdl-34260272

Assuntos

COVID-19; Anticorpos Antivirais; Humanos; Imunoglobulina G; Pandemias; SARS-CoV-2; Sensibilidade e Especificidade; África do Sul

Palavras-chave

COVID-19; SARS-CoV-2; analytical performance; antibody assay; evaluation; harmonization; serology; variants

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google